Which are the causes of Hereditary Angioedema?

Hereditary Angioedema is primarily caused by a genetic mutation that leads to a deficiency or dysfunction of the C1 esterase inhibitor protein, resulting in uncontrolled swelling episodes.

The Genetic Mechanism

In most cases, Hereditary Angioedema is an autosomal dominant condition, meaning you only need to inherit the gene mutation from one parent to develop the disease. This mutation occurs in the SERPING1 gene, which provides instructions for making the C1 esterase inhibitor. Think of this protein as a “security guard” for your immune system; when the guard is missing or inactive, certain inflammatory pathways become hyperactive, leading to the rapid accumulation of bradykinin, a peptide that causes blood vessels to leak fluid into surrounding tissues, resulting in the characteristic swellings of Hereditary Angioedema.

Triggers vs. Causes

It is vital to distinguish between the underlying cause and environmental triggers. While the genetic mutation is the root cause, many patients report that specific events can act as "triggers" for an attack. Common triggers include physical trauma, dental procedures, emotional stress, or even minor illnesses. These factors do not cause Hereditary Angioedema, but they can stress the body’s regulatory systems enough to provoke a swelling episode in a person who already carries the genetic predisposition.

Current Research and Etiology

While the role of the SERPING1 gene is well-established, researchers are still investigating why some individuals with the same genetic mutation experience severe, frequent symptoms while others remain relatively mild. Current clinical research is focused on identifying "modifier genes" and epigenetic factors that may influence individual disease severity. Scientists are also exploring how the lymphatic and circulatory systems interact with these inflammatory pathways to better understand why certain parts of the body are more susceptible to swelling in Hereditary Angioedema patients. Understanding these nuances is the key to developing more personalized therapeutic approaches beyond current treatments like Cinryze or Berinert.

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: The portal for rare diseases and orphan drugs


• Online Mendelian Inheritance in Man (OMIM)


• U.S. Hereditary Angioedema Association (HAEA)